inflammatory system have been proposed and recent research links these inflammatory processes with cognitive function, suggesting that the presence of inflammation is associated with poorer cognitive performance (Ribeiro-Santos et al., 2014, Cabrera et al., 2016. The study of the influence of gender on the possible association between inflammatory biomarkers and cognitive performance may favor the implementation of personalized treatments. The aim of the study is to investigate the association between inflammatory biomarkers and gender-based cognition in a sample of first psychotic episode (FEP). A total of 92 patients with a FEP, 62 men and 30 women, recruited in five clinical centers were included. A neurocognitive assessment was performed and the expression of pro and anti-inflammatory mediators in peripheral blood mononuclear cells (PBMC) and plasma was measured. Methods: In the neurocognitive evaluation the domains of attention, verbal and working memory and executive function were included. Other and clinical variables included the assessment of psychotic and affective symptoms, age, sex, educational level and socio-economic level. The expression of the proinflammatory mediators (NFκB, iNOS, COX-2, PGE2, NO-2 and TBARS) and anti-inflammatory (15d-PGJ2, PPARγ and IκBα) of the main intracellular inflammatory pathway was measured in PBMC and plasma. Results: A correlation was made between inflammatory biomarkers and neurocognitive performance according to gender, and significant associations were selected to perform a subsequent hierarchical regression analysis. In the final model, only the expression of COX2 was associated with better performance in executive function in males (B = 0.504, p = <0.001) and the expression of NO2 to worse performance in working memory in women (B = -0.911; p = 0.010), after controlling the confounding factors. Men and women did not differ in any of the confusing variables. Discussion: The expression of certain pro / anti-inflammatory components could have a differential effect according to the gender of patients with FEP. The expression of COX2 could be beneficial in the case of males, explaining part of the variability in executive function. On the contrary, the expression of NO2 could have a detrimental effect on working memory in women. The establishment of biomarkers linked to gender-based cognition could be useful for monitoring the course of cognitive decline and could guide treatment programs, providing tools to select a personalized approach. 
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F13. TOWARDS MOLECULAR INSIGHTS INTO PSYCHIATRIC DISORDERS USING AFFINITY PROTEOMICS

Uppsala University
Background: Numerous studies have shown a correlation between high autoantibody titers and subsequent autoimmune disease in patients with psychiatric disorders compared to healthy individuals. In this study we used a targeted affinity proteomics approach to investigate these autoantibody repertoires. We therefore obtained serum samples from patients diagnosed with various psychiatric disorders and compared these with samples of healthy volunteers. Additionally we used our approach to identify autoantibodies in post mortem brain tissue from patients diagnosed with schizophrenia. Methods: In this study we utilized a well characterized cohort of patients with psychiatric disorder to study the autoantibody repertoire. From this sample set we analysed more than 600 serum in a first discovery approach. Based on the in-house screening and previous external published studies of autoantibodies within psychiatry we selected a set of 231 protein fragments from the Human Protein Atlas with a length of roughly 80 amino acids.
With this selected panel we screened additional 130 post mortem brain tissue samples. Autoantibody profiling was performed using suspension bead array technology and IgG reactivity was measured in patients and controls.
Results: Our findings could indicate altered immune response in patients with psychiatric disorders compared to healthy controls. In our study we identified potential predictive autoimmune signatures. Those were presented with higher IgG reactivity in patients compared to healthy control samples. Discussion: With our approach we were able to profile autoantibody repertoires in patients with psychiatric disorders. Additionally, we were able to use our approach to profile brain tissue using a multiplexed affinity proteomics approach. By further validating these putative autoimmunity targets, we could gain insights into the autoantigens associated to chronical mental illnesses. Background: Abnormal mismatch negativity (MMN), thought to be a putative marker of glutamatergic function, has been reported in non-Asian, first episode schizophrenia and clinical high-risk for psychosis (CHR) individuals as indicative of impairments in pre-attentive processes. However, reports of abnormal MMN in Asian populations are sparse, as well as its relationships to glutamate and γ-aminobutyric acid (GABA) levels in medial prefrontal cortex. The present longitudinal study explored MMN differences between CHR subjects who will and who will not remit, and its relationships with prefrontal glutamate and GABA levels. Methods: All subjects participated in the ShangHai At-Risk for Psychosis (SHARP) program. CHR subjects met the criteria defined by the Chinese version of the Structural Interview for Prodromal Syndromes (SIPS). From the SHARP sample, 76 CHR subjects (41 male, age 18.63 ± 5.02 years) and 53 HC (31 male, age 17.72 ± 3.18 years) completed both MMN test and proton magnetic resonance spectroscopy (1H MRS) scans using a MEGA-PRESS sequence at their initial visit. CHR subjects were divided into remitted (37) and non-remitted (34) individuals based on their clinical symptoms and functional scores at a one-year follow up. Duration MMN amplitude was measured at electrodes F1/2, Fz, FC1/2, FCz, C1/2 and Cz. Concentrations of glutamate+glutamine (Glx) and GABA in the medial prefrontal cortex (mPFC) were quantified using the LCModel software (version 6.3-0I). Repeated measures analysis of variance (ANOVA) with group (remitted CHR, non-remitted CHR and HC) as the between-group factor and electrodes (Fz, FCz and Cz) as the within-group factor were performed for the midline sites, and the ANOVA using F1/2, FC1/2 and C1/C2 with laterality (left and right hemisphere) as an additional within-group factor was performed for the lateral sites. Correlations of the dMMN amplitude (averaged over the 9 electrodes) and Glx and GABA concentrations were assessed by Pearson correlation tests for each group. Results: There was a significant main effect of group (F(2,121)=3.14, p<0.05) for the midline fronto-central dMMN amplitude. Post-hoc tests showed that non-remitted CHR subjects had lower baseline dMMN amplitude (-4.75 ± 0.37μv) than HC (-5.92 ± 0.30μv, p<0.05), whereas dMMN in remitted CHR (-5.22 ± 0.36μv, p=0.41 ) was comparable to dMMN in HC. The main effect of group was marginally significant at lateral sites (F(2,121)=2.83, p=0.06). DMMN amplitude in non-remitted CHR (-4.67 ± 0.37μv) tended to be lower than those in HC (-5.76 ± 0.29μv,
F14. REDUCED DURATION MISMATCH NEGATIVITY ASSOCIATED WITH DECREASED GLUTAMATE+GLUTAMINE LEVEL IN SUBJECTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
